IMVT Operating Cash Flow (Statement)
Immunovant Inc · Operating Cash Flow (Statement)
IMVT Operating Cash Flow (Statement)
Latest reported-$414.30Mperiod ending
IMVT TTM Cash from Operations (-$986.20K → -$414.30M)
TTM operating cash flow (statement)
High-resolution chart · PNG
IMVT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -414,304,000 | |
| -407,310,000 | |
| -422,888,000 | |
| -430,954,000 | |
| -417,086,000 | |
| -375,874,000 | |
| -324,936,000 | |
| -271,643,000 | |
| -243,056,000 | |
| -214,227,000 | |
| -210,321,000 | |
| -209,618,000 | |
| -169,744,000 | |
| -188,193,000 | |
| -165,356,000 | |
| -150,856,000 | |
| -150,717,000 | |
| -106,112,000 | |
| -95,652,000 | |
| -86,572,000 | |
| -90,743,000 | |
| -83,327,000 | |
| -83,881,000 | |
| -61,070,418 | |
| -37,153,920 | |
| -23,586,203 | |
| -986,203 | |
| -8,369,397 | |
| -11,513,448 | |
| -16,347,132 |